X
1. 503615-03-0
2. 3-(4-morpholinyl)-1-(4-nitrophenyl)-5,6-dihydro-2(1h)-pyridinone
3. 5,6-dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1h)-pyridinone
4. 5-morpholin-4-yl-1-(4-nitrophenyl)-2,3-dihydropyridin-6-one
5. 2(1h)-pyridinone, 5,6-dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-
6. Mfcd19440872
7. 3-(morpholinyl)-n-(4-nitrophenyl)-5,6-dihydropyridin-2-one
8. Schembl1995413
9. Dtxsid90620357
10. Amy31239
11. Bcp11848
12. Cs-m1442
13. Akos015951080
14. Zinc100004338
15. As-19240
16. Da-18294
17. Sy227010
18. Ft-0754958
19. A846988
20. 3-morpholino-1-(4-nitrophenyl) -5,6-dihydropyridin-2(1h)-one
21. 3-(morpholin-4-yl)-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1h)-one
22. 3-morpholin-4-yl-1-(4-nitro-phenyl)-5,6-dihydro-1h-pyridin-2-one
23. 5,6-dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1h)-pyridinone;3-morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1h)-one
| Molecular Weight | 303.31 g/mol |
|---|---|
| Molecular Formula | C15H17N3O4 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 303.12190603 g/mol |
| Monoisotopic Mass | 303.12190603 g/mol |
| Topological Polar Surface Area | 78.6 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 460 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
List of SuppliersNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
In-cosmetics Global
Not Confirmed
Contact Supplier
In-cosmetics Global
Not Confirmed
Contact Supplier
Market Place
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
